Definitive Contract W81XWH15C0102

Award Date 9/28/15
Potential Completion Date 4/27/16
Potential Value $150K
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Owego, NY 13827, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
192
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,009,937.61 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to X-Therma Inc., a minority-owned, woman-owned small business. The contract is for the development of advanced cryoprotectants and their application to the preservation of porcine kidneys ex vivo at sub-zero temperatures, with the goal of significantly extending the ischemia window of human-sized organs up to 120 hours. This work is also supported by additional grants...
This is a $150,000.00 firm fixed price contract awarded by the U.S. Army Medical Command (MEDCOM) to Sylvatica Biotech Inc., a minority-owned small business, under the Department of Defense (DoD) Small Business Innovation Research (SBIR) Program Phase I. The contract supports research and development of novel cryostasis solutions to enable high subzero banking of human organs. This work builds on Sylvatica's prior SBIR Phase I efforts and will be performed in Charleston, South Carolina through...
This is a $1,010,000.00 firm-fixed-price Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Medical Command (MEDCOM) to Sylvatica Biotech Inc., a minority-owned small business. The contract supports further research and development of a novel cryostasis cocktail and protocol to enable high subzero banking of human organs, building upon prior SBIR Phase I work. The contract has a performance period through November 2019 and will be executed in Charleston, South...
This is a $149,999.08 Firm Fixed Price contract awarded by the Medical Command (MEDCOM) of the U.S. Department of the Army to Tissue Testing Technologies LLC, a small disadvantaged business, for a SBIR Phase I research project titled "Avoiding the Ice Cryolesion in Tissue Cryopreservation with Ice Modulators." The contract is focused on developing vitrification techniques and solutions to extend storage times and improve outcomes for transplantable tissues and organs. This award is...
This is a $154,635 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to X-Therma Inc., a minority-owned, woman-owned small business. The contract supports the development of advanced cryoprotectants and their application to the preservation of porcine kidneys ex vivo at subzero temperatures, with the goal of significantly extending the ischemia window of human-sized organs up to 120 hours. This work aligns with...
This federal contract award was made by a U.S. government agency to Physical Sciences Inc. (PSI), a for-profit research and development company. The contract is for the development of a process end point monitor for lyophilized biologic drugs for cancer treatment, under the Small Business Innovation Research (SBIR) Phase I program. The contract is a definitive, firm-fixed-price contract with a ceiling value of $299,985.00. The place of performance is Andover, MA. PSI is an experienced government...
This is a Firm Fixed Price SBIR Phase II contract award from the Department of Defense's Medical Command (MEDCOM) to TDA Research, Inc., a small business subchapter S corporation located in Colorado. The $1,497,623.14 contract is for the development of "Optimal Rewarming Solutions for Cryopreserved Tissue Systems", which supports MEDCOM's medical research and development efforts. The contract has a period of performance through February 4, 2025. TDA Research, Inc. is an experienced...
This is a $149,991.20 firm fixed-price SBIR Phase I contract awarded by the U.S. Army Medical Command to X-Therma Inc., a minority-owned, woman-owned small business. The contract is for the development of advanced cryoprotectants and their application to the preservation of porcine kidneys ex vivo at subzero temperatures, with the goal of significantly extending the ischemia window of human-sized organs up to 120 hours. This work is part of X-Therma's broader efforts to advance regenerative...
This federal contract award W81XWH16C0155 was made by the U.S. Army Medical Command (MEDCOM) to Tissue Testing Technologies LLC, a small disadvantaged business, for the SBIR (Small Business Innovation Research) Phase I project "TISSUE TESTING TECHNOLOGIES". The $149,999.98 fixed-price contract is for research and development related to organ and tissue preservation and banking, with a focus on vitrification techniques and solutions to extend storage times and improve outcomes for...
This is a $149,998.99 Phase I SBIR (Small Business Innovation Research) contract awarded by the Department of the Army Medical Command to Mainstream Engineering Corp, a for-profit manufacturer and research company. The contract, titled "PASSIVELY REGULATED CRYOGENIC (PARC) VIAL SYSTEM FOR VACCINE DISTRIBUTION AND ADMINISTRATION," is for research and development of a specialized cryogenic vial system to support vaccine distribution and administration. As a Phase I SBIR award, this...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Cell Preservation Services Inc. (CPSI Biotech), a biotechnology company specializing in cryopreservation and thermal ablation technologies. The $149,973.45 Firm Fixed Price contract is for the project "OPTIMAL REWARMING SOLUTIONS FOR CRYOPRESERVED TISSUE SYSTEMS," which aims to develop innovative solutions for cell preservation, particularly in the areas of cancer immunotherapy and diabetes management. As an SBIR Phase I award, this contract supports early-stage research and development activities. CPSI Biotech has received other federal grant awards from the National Institutes of Health, demonstrating their expertise in cryopreservation and thermal ablation technologies and their commitment to advancing medical treatments across multiple therapeutic areas.

Generated 4/2/25, 6:59 PM